KLF4 and cancer: Silencing of miR-218-5p inhibited activation of the JAK2/STAT3 pathway by targeting KLF9 [61], while KLF4, which belongs to the same family, could inhibit the JAK2/STAT3 pathway, which in turn affects cancer cell development [62].